迅速診断キットの世界市場：洞察、競合情勢、市場予測：2030年

世界の迅速診断キットの市場規模は、2023年に141億2,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に3.55％ｎCAGRで拡大し、2030年には173億8,000万米ドルに達すると予測されています。迅速診断キット市場の堅調な成長は、世界の糖尿病有病率の上昇、COVID-19有病率の上昇、ヒト免疫不全ウイルス（HIV）感染率の上昇、市場における迅速診断キットの規制承認の増加、ポイントオブケア免疫診断テストの需要増加が主な要因であり、2024年から2030年までの予測期間中に迅速診断キット市場を推進しています。

迅速診断キット市場は、世界の糖尿病有病率の上昇など様々な要因により、現在有利な成長を遂げています。2022年の国際糖尿病連合によると、約5億3,700万人の成人（20～79歳）が糖尿病を患っています。上記の情報源によると、2030年には世界中で6億4,300万人が糖尿病に罹患し、2045年には7億8,300万人が糖尿病に罹患するといいます。

さらに、迅速診断キット市場の成長をもたらすもう一つの重要な要因は、COVID-19の有病率の上昇です。例えば、WHOの2022年6月の発表によると、世界中で540,923,532人のCOVID-19が確認されており、そのうち6,325,785件が死亡しています。 前述の情報源によれば、2019年のCOVID-19急増により、迅速診断キットの需要と生産を押し上げました。COVID-19ウイルスに関連するウイルスタンパク質（抗原）は、人の気道のサンプルを採取することによって迅速診断試験（RDT）によって検出することができ、これは迅速かつ正確な診断を保証します。したがって、COVID-19の流行とそれに関連する死亡の増加は、迅速診断キットの助けを借りてウイルスの早期診断を行うことによって制限することができ、これは迅速診断キットの需要を増加させ、迅速診断キットの全体的な市場の成長を急増させます。

当レポートでは、世界の迅速診断キット市場について調査し、市場の概要とともに、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 迅速診断キット市場レポートのイントロダクション

第2章 迅速診断キット市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 迅速診断キット市場の主な要因分析

• 迅速診断キット市場の促進要因
• 迅速診断キット市場の抑制要因と課題
• 迅速診断キット市場の機会

第5章 迅速診断キット市場におけるポーターのファイブフォース分析

第6章 迅速診断キット市場に対するCOVID-19の影響分析

第7章 迅速診断キット市場概要

• 技術別
• 用途別
• エンドユーザー別
• 地域別

第8章 迅速診断キットの世界企業シェア分析-主要3～5社

第9章 迅速診断キットの企業と製品プロファイル

• Advin Health Care
• ACON Laboratories Inc
• Abbott
• Artron Laboratories Inc
• Alfa Scientific Designs Inc
• BD
• BTNX Inc
• bioMerieux SA
• Cardinal Health
• Lab-Care Diagnostics (India) Pvt. Ltd
• Creative Diagnostics
• Meridian Bioscience Inc
• F. Hoffmann-La Roche Ltd
• Trinity Biotech
• WERFEN
• Elabscience Biotechnology Inc
• Innova Medical Group Inc
• CTK Biotech Inc
• Atlas Medical GmbH
• Wondfo

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Rapid Diagnostics Kits Market in Global (2021-2030)
• Table 4: Rapid Diagnostics Kits Market in Global by Technology (2021-2030)
• Table 5: Rapid Diagnostics Kits Market in Global by Application (2021-2030)
• Table 6: Rapid Diagnostics Kits Market in Global by End-User Type (2021-2030)
• Table 7: Rapid Diagnostics Kits Market in Global by Geography (2021-2030)
• Table 8: Rapid Diagnostics Kits Market in North America (2021-2030)
• Table 9: Rapid Diagnostics Kits Market in North America by Country (2021-2030)
• Table 10: Rapid Diagnostics Kits Market in the US (2021-2030)
• Table 11: Rapid Diagnostics Kits Market in Canada (2021-2030)
• Table 12: Rapid Diagnostics Kits Market in Mexico (2021-2030)
• Table 13: Rapid Diagnostics Kits Market in Europe (2021-2030)
• Table 14: Rapid Diagnostics Kits Market in Europe by Country (2021-2030)
• Table 15: Rapid Diagnostics Kits Market in France (2021-2030)
• Table 16: Rapid Diagnostics Kits Market in Germany (2021-2030)
• Table 17: Rapid Diagnostics Kits Market in the United Kingdom (2021-2030)
• Table 18: Rapid Diagnostics Kits Market in Italy (2021-2030)
• Table 19: Rapid Diagnostics Kits Market in Spain (2021-2030)
• Table 20: Rapid Diagnostics Kits Market in Russia (2021-2030)
• Table 21: Rapid Diagnostics Kits Market in Rest of Europe (2021-2030)
• Table 22: Rapid Diagnostics Kits Market in APAC (2021-2030)
• Table 23: Rapid Diagnostics Kits Market in APAC by Country (2021-2030)
• Table 24: Rapid Diagnostics Kits Market in China (2021-2030)
• Table 25: Rapid Diagnostics Kits Market in Japan (2021-2030)
• Table 26: Rapid Diagnostics Kits Market in India (2021-2030)
• Table 27: Rapid Diagnostics Kits Market in Australia (2021-2030)
• Table 28: Rapid Diagnostics Kits Market in South Korea (2021-2030)
• Table 29: Rapid Diagnostics Kits Market in Rest of APAC (2021-2030)
• Table 30: Rapid Diagnostics Kits Market in Rest of World (2021-2030)
• Table 31: Rapid Diagnostics Kits Market in RoW by Region (2021-2030)
• Table 32: Rapid Diagnostics Kits Market in Middle East (2021-2030)
• Table 33: Rapid Diagnostics Kits Market in Africa (2021-2030)
• Table 34: Rapid Diagnostics Kits Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Rapid Diagnostics Kits Market in Global (2021-2030)
• Figure 4: Rapid Diagnostics Kits Market in Global by Technology (2021-2030)
• Figure 5: Rapid Diagnostics Kits Market in Global by Application (2021-2030)
• Figure 6: Rapid Diagnostics Kits Market in Global by End-User Type (2021-2030)
• Figure 7: Rapid Diagnostics Kits Market in Global by Geography (2021-2030)
• Figure 8: Rapid Diagnostics Kits Market in North America (2021-2030)
• Figure 9: Rapid Diagnostics Kits Market in North America by Country (2021-2030)
• Figure 10: Rapid Diagnostics Kits Market in the US (2021-2030)
• Figure 11: Rapid Diagnostics Kits Market in Canada (2021-2030)
• Figure 12: Rapid Diagnostics Kits Market in Mexico (2021-2030)
• Figure 13: Rapid Diagnostics Kits Market in Europe (2021-2030)
• Figure 14: Rapid Diagnostics Kits Market in Europe by Country (2021-2030)
• Figure 15: Rapid Diagnostics Kits Market in France (2021-2030)
• Figure 16: Rapid Diagnostics Kits Market in Germany (2021-2030)
• Figure 17: Rapid Diagnostics Kits Market in the United Kingdom (2021-2030)
• Figure 18: Rapid Diagnostics Kits Market in Italy (2021-2030)
• Figure 19: Rapid Diagnostics Kits Market in Spain (2021-2030)
• Figure 20: Rapid Diagnostics Kits Market in Russia (2021-2030)
• Figure 21: Rapid Diagnostics Kits Market in Rest of Europe (2021-2030)
• Figure 22: Rapid Diagnostics Kits Market in APAC (2021-2030)
• Figure 23: Rapid Diagnostics Kits Market in APAC by Country (2021-2030)
• Figure 24: Rapid Diagnostics Kits Market in China (2021-2030)
• Figure 25: Rapid Diagnostics Kits Market in Japan (2021-2030)
• Figure 26: Rapid Diagnostics Kits Market in India (2021-2030)
• Figure 27: Rapid Diagnostics Kits Market in Australia (2021-2030)
• Figure 28: Rapid Diagnostics Kits Market in South Korea (2021-2030)
• Figure 29: Rapid Diagnostics Kits Market in Rest of APAC (2021-2030)
• Figure 30: Rapid Diagnostics Kits Market in Rest of World (2021-2030)
• Figure 31: Rapid Diagnostics Kits Market in RoW by Region (2021-2030)
• Figure 32: Rapid Diagnostics Kits Market in Middle East (2021-2030)
• Figure 33: Rapid Diagnostics Kits Market in Africa (2021-2030)
• Figure 34: Rapid Diagnostics Kits Market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

Rapid Diagnostic Kits Market By Technology (Lateral Flow Tests, Immunoassay, Agglutination, And Solid Phase), By Application (Infectious Diseases, Fertility Tests, Glucose Monitoring, Cholestrol Monitoring And Others), By End User (Hospitals, Clinics, Home Care, And Diagnostic Centers), and by geography, is expected to grow at a significant CAGR forecast till 2030 owing to the rising prevalence of diabetes globally and the increasing prevalence of covid-19

The global rapid diagnostic kits market was valued at USD 14.12 billion in 2023, growing at a CAGR of 3.55% during the forecast period from 2024 to 2030, to reach USD 17.38 billion by 2030. The stellar growth observed in the rapid diagnostic kits market is primarily owing to the rising prevalence of diabetes globally, the increasing prevalence of COVID-19, the increasing incidence of Human Immunodeficiency Virus (HIV) infection, the increased regulatory approval of rapid diagnostics kits in the market, and the increase in demand of point-of-care immunodiagnostic tests are some of the factors propelling the market for rapid diagnostic kits during the forecast period from 2024 to 2030.

Rapid Diagnostic Kits Market Dynamics:

The rapid diagnostic kits market is witnessing lucrative growth at present owing to various factors such as the rising prevalence of diabetes globally. As per the International Diabetes Federation in 2022, around 537 million adults (20-79 years) were living with diabetes. According to the above mentioned source, by the year 2030, there will be 643 million people who will suffer from diabetics worldwide, and by the year 2045, there will be 783 million people suffering from the disease. Thus, the rapid diagnostics kits which includes the glucometer with strips which are used for the glucose monitoring for quick results. Therefore, this can boost the demand of rapid diagnostics kits, thereby, blostering the growth of rapid diagnostics kits overall market over the forecast period (2024-2030).

Moreover, another key factor that is responsible for the growth of the rapid diagnostics kits market is the increasing prevalence of COVID-19. For instance, according to the WHO June 2022, there have been 540,923,532 confirmed cases of COVID-19 all over the world including 6,325,785 deaths. As per the aforesaid source, the spike in COVID-19 cases in 2019 boosted the demand and production of rapid diagnostics kits. The viral proteins (antigens) associated with the COVID-19 virus can be detected by a rapid diagnostic test (RDT) by taking the sample of a person's respiratory tract, this assures a quick and accurate diagnosis. Therefore, the increasing prevalence of COVID-19 and deaths related to it can be limited by doing an early diagnosis of the virus with the help of rapid diagnostics kits, this increases the demand for rapid diagnostics kits which surges the rapid diagnostics kit's overall market growth.

Hence, all the aforementioned factors are anticipated to boost the global rapid diagnostic kits market during the forecast period.

However, the low sensitivity & accuracy of rapid diagnostic kits and stringent regulatory approval policies are some of the factors likely to impede the rapid diagnostic kits market growth.

Additionally, the ongoing COVID-19 pandemic has positively impacted the rapid diagnostics kits market. The surge in COVID-19 cases across the globe generated a huge demand for rapid diagnostics kits to detect the presence of disease in an individual. Home self-testing kits demand for COVID-19 increased as well as the severe shortage of rapid diagnostics kits related to glucose monitoring and others was reported. As the masses are vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, and manufacturing units, the rapid diagnostics kits overall market can be expected to further grow during the forecast period (2024-2030).

Rapid Diagnostic Kits Market Segment Analysis:

Rapid Diagnostic Kits Market by Technology (Lateral Flow Tests, Immunoassay, Agglutination, and Solid Phase), Application (Infectious Diseases, Fertility Tests, Glucose Monitoring, Cholestrol Monitoring, and Others), End-User (Hospitals, Clinics, Home Care, and Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the rapid diagnostic kits market, the infectious diseases sub-segment is expected to hold the largest market share in the year 2023. This is because of the sudden spike of infectious diseases such as COVID-19 cases in 2019, rapid diagnostics kits helped in the early diagnosis of the virus. It acts as a useful technique for determining the clinical diagnosis of COVID-19 in which antibodies are spotted on nitrocellulose membranes and interact with certain antigens in the patient's sample. Some advantages of rapid diagnostics kits are people have easier access to the test, it allows the implementation of proper infection control measures early, which is critical in a pandemic, and it is an easy-to-use test that yields findings in 20 minutes or less, with little or no additional equipment needed. Thus, the benefits associated with the rapid diagnostics kits, its market demand increases which boosts its overall market growth.

Therefore, the surge in infectious diseases cases worldwide, can increase the demand for rapid diagnostics kits which could drive the growth of the overall rapid diagnostics kits market during the forecast period. However, various technological advanced products are launched in the market which are also expected to drive the market growth. For instance, in January 2022, Roche Diagnostics, the world's largest biotech company, announced the release of the COVID-19 At-Home Test, their newest diagnostic solution. The ICMR has authorized the over-the-counter test for the identification of SARS CoV-2 infection in those who have symptoms that are similar to COVID-19.

Further, in July 2022, Abbott, a global healthcare leader announced the launch of the Panbio(TM) COVID-19 Antigen Self-Test for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.

Hence, all the above-mentioned factors are anticipated to contribute to the growth of the rapid diagnostic kits market during the forecast period.

North America is expected to dominate the overall Rapid Diagnostic Kits Market:

Among all the regions, North America is expected to occupy a major share in the global rapid diagnostic kits market in the year 2023 and continue to do the same during the forecast period from 2024 to 2030. Factors such as the increasing incidence of HIV infections and the increasing regulatory approval of rapid diagnostics kits in the market are expected to increase the demand for rapid diagnostics kits in the North America market.

According to HIV.gov in 2019, in United States, 34,800 new cases of HIV infections were estimated with the rate of 12.6 per 100,000 people. Therefore, rapid diagnostics kits can be used for the diagnosis of the HIV infection, this can uplift the demand of rapid diagnostics kits, which could boost the rapid diagnostics kits overall market.

Furthermore, pregnancy test kits are utilized to detect the pregnancy in the women. Thus, due to surge in pregnancy and birth rates, regulatory approval of pregnancy diagnostics kits has increased in the market, which can also drive the rapid diagnostics kits overall market. For instance, in December 2020, ACON Laboratories Inc., a leading global of rapid tests, point of care diagnostics and medical devices announced that it has received FDA Over The Counter (OTC) clearance for its Distinct® Early Detection Pregnancy test in the United States.

Therefore, due to interplay of the factors mentioned above, there will be high demand of rapid diagnostics kits, which would provide a conducive growth environment for the North American region in the rapid diagnostics kits market.

Rapid Diagnostic Kits Market Key Players:

Some of the key market players operating in the rapid diagnostic kits market include Advin Health Care, ACON Laboratories Inc, Abbott, Artron Laboratories Inc, Alfa Scientific Designs Inc, BD, BTNX Inc, bioMerieux SA, Cardinal Health, Lab-Care Diagnostics (India) Pvt. Ltd., Creative Diagnostics, Meridian Bioscience Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech, WERFEN, Elabscience Biotechnology Inc, Innova Medical Group Inc, CTK Biotech Inc , Atlas Medical GmbH, Wondfo, and others.

Recent Developmental Activities in the Rapid Diagnostic Kits Market:

In February 2022, Kenya's Ministry of Health launched malaria and COVID-19 PCR diagnostic kits in a bid to increase the timely detection and treatment of both infections.

In June 2022, MyLab Discovery Solutions announced the commercial launch of their COVID-19 self-test kit CoviSelf in India after getting approval from the Indian Council for Medical Research (ICMR). It can detect the virus within 15 minutes. It is the first test kit for Covid-19 that can be self-administered by citizens at home.

In March 2020, Biolidics Limited, a medical technology firm, announced the debut of their quick test kit for the Novel Coronavirus 2019 ("COVID-19") in Singapore, as well as a manufacturing agreement with a diagnostic kit manufacturer to customize and produce the rapid test kits.

Key Takeaways from the Rapid Diagnostic Kits Market Report Study

• Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the rapid diagnostic kits market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened over the last 3 years
• Key companies dominating the Global rapid diagnostic kits Market
• Various opportunities available for the other competitor in the rapid diagnostic kits Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for rapid diagnostic kits market growth in the coming future?

Target Audience who can be benefited from the Rapid Diagnostic Kits Market Report Study

• Rapid diagnostic kits providers
• Research organizations and consulting companies
• Rapid diagnostic kits-related organization, association, forum, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders in Rapid Diagnostic Kits
• Various End-users who want to know more about the Rapid Diagnostic Kits Market and the latest technological developments in the Rapid Diagnostic Kits market.

Frequently Asked Questions for the Rapid Diagnostic Kits Market:

1. What is Rapid Diagnostic Kits?

Rapid Diagnostic Kits help in point-of-care diagnosis, which means they're designed to give patients diagnostic findings quickly and easily while they're still at the hospital, screening site, or other health care provider.

2. What is the market for Global Rapid Diagnostic Kits?

The global Rapid Diagnostic Kits Market was valued at USD 14.12 billion in 2023, growing at a CAGR of 3.55% during the forecast period from 2024 to 2030 to reach USD 17.38 billion by 2030.

3. What are the drivers for Global Rapid Diagnostic Kits?

The major factor driving the demand for rapid diagnostic kits are the rising prevalence of diabetes globally, the increasing prevalence of COVID-19, the increasing incidence of Human Immunodeficiency Virus (HIV) infection, the increased regulatory approval of rapid diagnostics kits in the market, and increase in the demand of point-of-care immunodiagnostic tests

4. What are the key players operating in Global Rapid Diagnostic Kits?

Some of the key market players operating in the rapid diagnostic kits market include Advin Health Care, ACON Laboratories Inc, Abbott, Artron Laboratories Inc, Alfa Scientific Designs Inc, BD, BTNX Inc, bioMerieux SA, Cardinal Health, Lab-Care Diagnostics (India) Pvt. Ltd., Creative Diagnostics, Meridian Bioscience Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech, WERFEN, Elabscience Biotechnology Inc, Innova Medical Group Inc, CTK Biotech Inc. , Atlas Medical GmbH, Wondfo, and others.

5. Which region has the highest share in the Rapid Diagnostic Kits market?

Among all the regions, North America is expected to occupy a major share in the global rapid diagnostic kits market in the year 2023. This domination is owing to the increasing incidence of Human Immunodeficiency Virus (HIV) infection and the increased regulatory approval of rapid diagnostics kits in the market contributes to the growth of the rapid diagnostics kits market in the North America region.

Table of Contents

1.Rapid Diagnostic Kits Market Report Introduction

2.Rapid Diagnostic Kits Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Rapid Diagnostic Kits Market Key factors analysis

• 4.1. Rapid Diagnostic Kits Market Drivers
  • 4.1.1. The Rising Prevalence of Diabetes Globally
  • 4.1.2. The Increasing Incidence of Human Immunodeficiency Virus (HIV) Infection
  • 4.1.3. The Increasing Prevalence of COVID-19 Cases
  • 4.1.4. The Increasing Regulatory Approval of Rapid Diagnostics Kits in the Market
• 4.2. Rapid Diagnostic Kits Market Restraints and Challenges
  • 4.2.1. Low Sensitivity & accuracy of rapid diagnostics kits products
  • 4.2.2. Stringent regulatory approval for rapid diagnostics kits
• 4.3. Rapid Diagnostic Kits Market Opportunities
  • 4.3.1. Rising Market Launch of Rapid Diagnostics Kits Globally
  • 4.3.2. A surge in Home Use Applications of the Rapid Diagnostics Kits

5. Rapid Diagnostic Kits Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Rapid Diagnostic Kits Market

7. Rapid Diagnostic Kits Market layout

• 7.1. By Technology
  • 7.1.1. Lateral Flow Tests
  • 7.1.2. Immunoassay
  • 7.1.3. Agglutination
  • 7.1.4. Solid Phase
• 7.2. By Application
  • 7.2.1. Infectious Diseases
  • 7.2.2. Fertility Tests
  • 7.2.3. Glucose Monitoring
  • 7.2.4. Cholesterol Monitoring
  • 7.2.5. Others
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Clinics
  • 7.3.3. Home Care
  • 7.3.4. Diagnostics Centers
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Rapid Diagnostics Kits Market Size in USD million (2019- 2030)
    • 7.4.1.2. Canada Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.2.6. Russia Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.2.7. Rest of Europe Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.3.3. India Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia Pacific Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Rapid Diagnostics Kits Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Rapid Diagnostics Kits Market Size in USD million (2021-2030)

8. Rapid Diagnostic Kits Global Company Share Analysis - Key 3-5 Companies

9. Rapid Diagnostic Kits Company and Product Profiles

• 9.1. Advin Health Care
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. ACON Laboratories Inc
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Abbott
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Artron Laboratories Inc
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Alfa Scientific Designs Inc
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. BD
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. BTNX Inc
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. bioMerieux SA
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Cardinal Health
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Lab-Care Diagnostics (India) Pvt. Ltd
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Creative Diagnostics
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Meridian Bioscience Inc
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. F. Hoffmann-La Roche Ltd
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Trinity Biotech
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. WERFEN
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Elabscience Biotechnology Inc
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Innova Medical Group Inc
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. CTK Biotech Inc
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Atlas Medical GmbH
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Wondfo
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us